@Article{,
AUTHOR = {Gabrielle R. Yankelevich, Kale Moreland, Makayla M. Swancutt, Robert L. Grubb},
TITLE = {Illuminating the use of photodynamic therapy in urologic oncology},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {31},
YEAR = {2024},
NUMBER = {6},
PAGES = {12035--12044},
URL = {http://www.techscience.com/CJU/v31n6/59552},
ISSN = {1488-5581},
ABSTRACT = {<b>Introduction:</b> We report the first scoping review of the
clinical urologic literature for photodynamic therapy
(PDT) among multiple urologic malignancies.<br/>
<b>Materials and methods:</b> A scoping review using
Medline and Embase was performed for treatment of
urologic malignancies with PDT.<br/>
<b>Results:</b> There were 84 papers included with the
majority involving bladder and prostate cancer. Upper
tract urothelial cancer (UTUC) only comprised three
publications and there was no clinical data for renal or testicular cancer. Utilizing PDT in prostate cancer led
to a negative biopsy rate of 30%-100%. Bladder cancer
treatment with PDT had a 3-month complete response
rate of 31.5%-100%. UTUC management with PDT
reported at least 50% complete response rate.<br/>
<b>Conclusions: </b>Ultimately, PDT has been established as a
safe and effective treatment for urologic malignancies and
we provide the first comprehensive review of the literature
regarding the utility of this treatment modality.},
DOI = {}
}